Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Bispecific Antibody Drug Market by Type (Fragment-Based, IgG-Based), By Application (Cancer, Haemophilia, Other Diseases) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Bispecific Antibody Drug Market by Type (Fragment-Based, IgG-Based), By Application (Cancer, Haemophilia, Other Diseases) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 231534 4200 Pharma & Healthcare 377 140 Pages 4.6 (31)
                                          

Industry Growth Insights published a new data on “Bispecific Antibody Drug Market”. The research report is titled “Bispecific Antibody Drug Market research by Types (Fragment-Based, IgG-Based), By Applications (Cancer, Haemophilia, Other Diseases), By Players/Companies Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, Abbvie, Lindis Biotech, MacroGenics, Genmab, Immunocore Limited, Xencor, Merck, Affimed, Alphamab, Akeso, BeiGene”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Bispecific Antibody Drug Market Research Report

By Type

Fragment-Based, IgG-Based

By Application

Cancer, Haemophilia, Other Diseases

By Companies

Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, Abbvie, Lindis Biotech, MacroGenics, Genmab, Immunocore Limited, Xencor, Merck, Affimed, Alphamab, Akeso, BeiGene

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

140

Number of Tables & Figures

98

Customization Available

Yes, the report can be customized as per your need.


Global Bispecific Antibody Drug Industry Outlook


Global Bispecific Antibody Drug Market Report Segments:

The global Bispecific Antibody Drug market is segmented on the basis of:

Types

Fragment-Based, IgG-Based

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Cancer, Haemophilia, Other Diseases

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Roche
  2. Amgen
  3. Sanofi
  4. Pfizer
  5. Johnson & Johnson
  6. AstraZeneca
  7. Abbvie
  8. Lindis Biotech
  9. MacroGenics
  10. Genmab
  11. Immunocore Limited
  12. Xencor
  13. Merck
  14. Affimed
  15. Alphamab
  16. Akeso
  17. BeiGene

Global Bispecific Antibody Drug Market Overview


Highlights of The Bispecific Antibody Drug Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Fragment-Based
    2. IgG-Based
  1. By Application:

    1. Cancer
    2. Haemophilia
    3. Other Diseases
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Bispecific Antibody Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Bispecific Antibody Drug Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Bispecific antibody drug is a type of medication that combines two different antibodies to create one compound. This allows the medication to target two different proteins or cells in the body, which can improve its effectiveness.

Some of the key players operating in the bispecific antibody drug market are Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, Abbvie, Lindis Biotech, MacroGenics, Genmab, Immunocore Limited, Xencor, Merck, Affimed, Alphamab, Akeso, BeiGene.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bispecific Antibody Drug Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Bispecific Antibody Drug Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Bispecific Antibody Drug Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Bispecific Antibody Drug Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Bispecific Antibody Drug Market Size & Forecast, 2018-2028       4.5.1 Bispecific Antibody Drug Market Size and Y-o-Y Growth       4.5.2 Bispecific Antibody Drug Market Absolute $ Opportunity

Chapter 5 Global Bispecific Antibody Drug Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Bispecific Antibody Drug Market Size Forecast by Type
      5.2.1 Fragment-Based
      5.2.2 IgG-Based
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Bispecific Antibody Drug Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Bispecific Antibody Drug Market Size Forecast by Applications
      6.2.1 Cancer
      6.2.2 Haemophilia
      6.2.3 Other Diseases
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Bispecific Antibody Drug Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Bispecific Antibody Drug Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Bispecific Antibody Drug Analysis and Forecast
   9.1 Introduction
   9.2 North America Bispecific Antibody Drug Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Bispecific Antibody Drug Market Size Forecast by Type
      9.6.1 Fragment-Based
      9.6.2 IgG-Based
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Bispecific Antibody Drug Market Size Forecast by Applications
      9.10.1 Cancer
      9.10.2 Haemophilia
      9.10.3 Other Diseases
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Bispecific Antibody Drug Analysis and Forecast
   10.1 Introduction
   10.2 Europe Bispecific Antibody Drug Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Bispecific Antibody Drug Market Size Forecast by Type
      10.6.1 Fragment-Based
      10.6.2 IgG-Based
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Bispecific Antibody Drug Market Size Forecast by Applications
      10.10.1 Cancer
      10.10.2 Haemophilia
      10.10.3 Other Diseases
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Bispecific Antibody Drug Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Bispecific Antibody Drug Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Bispecific Antibody Drug Market Size Forecast by Type
      11.6.1 Fragment-Based
      11.6.2 IgG-Based
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Bispecific Antibody Drug Market Size Forecast by Applications
      11.10.1 Cancer
      11.10.2 Haemophilia
      11.10.3 Other Diseases
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Bispecific Antibody Drug Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Bispecific Antibody Drug Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Bispecific Antibody Drug Market Size Forecast by Type
      12.6.1 Fragment-Based
      12.6.2 IgG-Based
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Bispecific Antibody Drug Market Size Forecast by Applications
      12.10.1 Cancer
      12.10.2 Haemophilia
      12.10.3 Other Diseases
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Bispecific Antibody Drug Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Bispecific Antibody Drug Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Bispecific Antibody Drug Market Size Forecast by Type
      13.6.1 Fragment-Based
      13.6.2 IgG-Based
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Bispecific Antibody Drug Market Size Forecast by Applications
      13.10.1 Cancer
      13.10.2 Haemophilia
      13.10.3 Other Diseases
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Bispecific Antibody Drug Market: Competitive Dashboard
   14.2 Global Bispecific Antibody Drug Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Roche
      14.3.2 Amgen
      14.3.3 Sanofi
      14.3.4 Pfizer
      14.3.5 Johnson & Johnson
      14.3.6 AstraZeneca
      14.3.7 Abbvie
      14.3.8 Lindis Biotech
      14.3.9 MacroGenics
      14.3.10 Genmab
      14.3.11 Immunocore Limited
      14.3.12 Xencor
      14.3.13 Merck
      14.3.14 Affimed
      14.3.15 Alphamab
      14.3.16 Akeso
      14.3.17 BeiGene

Our Trusted Clients

Contact Us